Giovanni Tremolada

Giovanni Tremolada's research centers on bladder cancer, particularly the diagnosis, treatment, and outcomes of non-muscle-invasive and muscle-invasive bladder cancer, including surgical approaches like radical cystectomy and transurethral resection, and treatments such as BCG therapy and immunotherapy (pembrolizumab). The bibliographic record also includes some veterinary oncology and surgery studies, which may reflect collaborative or overlapping work in comparative oncology. This work is largely clinical and outcomes-focused, drawing on real-world data and multicenter studies to inform evidence-based urological cancer care.

Publication output has grown substantially over the last decade, rising from about 1 paper per year in 2017-2019 to 13-14 papers per year in 2025-2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026